[Staging cancers of the oral cavity according to the 8th edition of AJCC TNM system: Issues and recommendations].

Tumeurs de la cavité orale et classification TNM (8
Cancer Cavité orale ;Tumeur Depth of invasion Extension extra-ganglionnaire Extranodal extension Oral cavity Profondeur d’invasion Stade Stage

Journal

Annales de pathologie
ISSN: 0242-6498
Titre abrégé: Ann Pathol
Pays: France
ID NLM: 8106337

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 22 02 2022
revised: 07 12 2022
accepted: 12 12 2022
medline: 18 7 2023
pubmed: 24 2 2023
entrez: 23 2 2023
Statut: ppublish

Résumé

Stage of cancer at the time of the diagnosis is a key factor for the prognosis and the determination of appropriate treatment. Several cancer staging systems are used worldwide. The most useful staging system is the tumor, node and metastasis (TNM) staging system develop by the American Joint Committee on Cancer (AJCC) in collaboration with the Union for International Cancer Control (UICC) referred to as the AJCC TNM staging system. The AJCC TNM system classifies cancers by the size and extend of the primary tumor (T), involvement of regional lymph nodes (N) and the presence of distant metastases (M). AJCC and UICC periodically modify the AJCC TNM staging system according to newly acquired clinical, pathological and biological data improving understanding of cancer physiopathology. The 8th edition of AJCC TNM system is effective for cancer patients diagnosed on or after January 1, 2018. Here, we report the issues of the staging cancers of the oral cavity according to the 8th edition of AJCC TNM system. We focus on 2 new concepts defined in the 8th edition of AJCC TNM system: depth of invasion (DOI) and extranodal extension (ENE).

Identifiants

pubmed: 36822900
pii: S0242-6498(22)00209-7
doi: 10.1016/j.annpat.2022.12.003
pii:
doi:

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

289-297

Informations de copyright

Copyright © 2022. Published by Elsevier Masson SAS.

Auteurs

Vanessa Lacheretz-Szablewski (V)

Département de pathologie et d'oncobiologie, hôpital Gui De-Chauliac, CHU de Montpellier, université de Montpellier, France. Electronic address: v-szablewski@chu-montpellier.fr.

Renaud Garrel (R)

Département ORL et chirurgie maxillo-faciale, hôpital Gui De-Chauliac, CHU de Montpellier, université de Montpellier, France.

Constant Guillot (C)

Département ORL et chirurgie maxillo-faciale, hôpital Gui De-Chauliac, CHU de Montpellier, université de Montpellier, France.

Valérie Costes-Martineau (V)

Département de pathologie et d'oncobiologie, hôpital Gui De-Chauliac, CHU de Montpellier, université de Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH